0.5684

1.86% 0.0104

After Hours: .57 0.0016 +0.28%

Bone Biologics Corp (BBLG)

Overview News Price History Financials Why BBLG Down? Discussions Forecast Stock Split

Bone Biologics Corp stock is traded at $0.5684, with a volume of 15,089. It is up +1.86% in the last 24 hours and down -39.86% over the past month. Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.

Previous Close:

$0.558

Open:

$0.577

24h Volume:

15,089

Relative Volume:

0.05

Market Cap:

$1.03M

Revenue:

Net Income/Loss:

$-2.86M

P/E Ratio:

-0.2267

EPS:

-2.5071

Net Cash Flow:

$-2.57M

1W Performance:

-7.58%

1M Performance:

-39.86%

6M Performance:

-54.53%

1Y Performance:

-80.06%

1-Day Range:

$0.5437

$0.5774

1-Week Range:

$0.5402

$0.588

52-Week Range:

$0.5402

$2.89

Bone Biologics Corp Stock (BBLG) Company Profile

Name

Bone Biologics Corp

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(781) 552-4452

Address

2 BURLINGTON WOODS DRIVE,, BURLINGTON

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

BBLG's Discussions on Twitter

Compare BBLG vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BBLG Bone Biologics Corp	0.5684	1.10M	0	-2.86M	-2.57M	-2.5071
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Bone Biologics Corp Stock (BBLG) Latest News

Sep 03, 2026

A company developing bone products will meet investors in New York - Stock Titan

Sep 03, 2026

Aug 31, 2026

Bone Biologics (NASDAQ: BBLGW) Schedules Six Key Proposals for September 28 Shareholder Vote - Kalkine Media

Aug 31, 2026

Aug 26, 2026

Bone Biologics Corp Warrants (BBLGW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

Aug 26, 2026

Bone Biologics Corp Warrants (BBLGW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 26, 2026

Aug 25, 2026

Orthobiologics Market Report Examines Leading Companies And Growth Opportunities - openpr.com

Aug 25, 2026

Bone Biologics (NASDAQ:BSPK): What Could Its Scheduled Update Reveal? - Kalkine Media

Aug 25, 2026

Aug 22, 2026

Bone (BBLG): Finishes 3.47% Higher at $0.63 in Latest Trading; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance for the Current SessionETF Outflow Streak - vinanet.vn

Aug 22, 2026

Aug 21, 2026

Bone (BBLGW): Shows Minimal Net Change at $8.24 in Latest Trading; Chart Watch: the Supplied Trading Band Runs From $7.83 to $8.65 under the Current SnapshotPut Flow Alert - siam.in

Aug 21, 2026

Aug 19, 2026

Bone (BBLG) Chart: Finishes 3.47% Lower at $0.62 for the Current Session; the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotVolume Climax - vinanet.vn

Aug 19, 2026

Aug 18, 2026

Bone (BBLG) Results and Estimates: The Bottom-Line Figure Outpaces Its Comparison in the Current Update; Post-Report Move: The Stock Ends Down 2.58% in the Latest SessionEPS Growth Report - vinanet.vn

Aug 18, 2026

Bone Biologics (NASDAQ: BBLG) seeks 1-for-2 to 1-for-10 reverse split approval - Stock Titan

Aug 18, 2026

Price to sales forward of Bone Biologics Corp – NASDAQ:BBLGW - TradingView

Aug 18, 2026

Number of shareholders of Bone Biologics Corp – NASDAQ:BBLGW - TradingView

Aug 18, 2026

Aug 16, 2026